Kalvista Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Kalvista Pharmaceuticals Inc cash flow-to-debt ratio. Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow-to-Debt Ratio of -0.10x as of October 2025, meaning its operating cash flow of $-32.68 Million could theoretically repay 0% of its total liabilities ($322.93 Million) in one year. Check cash flow reinvestment rate of Kalvista Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kalvista Pharmaceuticals Inc (2013–2025)
Cash flow-to-debt ratio of Kalvista Pharmaceuticals Inc from 2013 to 2025. Historical debt coverage capacity for Kalvista Pharmaceuticals Inc across 16 annual periods. See KALV equity to assets ratio to measure how much of total assets are equity-financed.
Kalvista Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
Kalvista Pharmaceuticals Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Kalvista Pharmaceuticals Inc. For the full cash flow conversion analysis, see Kalvista Pharmaceuticals Inc (KALV) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.98x | $-152.91 Million | $155.38 Million | ▲ +68.2% |
| 2024 | -3.10x | $-89.23 Million | $28.82 Million | ▲ +8.8% |
| 2023 | -3.39x | $-75.26 Million | $22.18 Million | ▲ +18.4% |
| 2022 | -4.16x | $-78.13 Million | $18.79 Million | ▼ -104.3% |
| 2021 | -2.04x | $-30.17 Million | $14.82 Million | ▲ +60.1% |
| 2020 | -5.11x | $-44.82 Million | $8.78 Million | ▼ -200.4% |
| 2019 | -1.70x | $-36.37 Million | $21.39 Million | ▼ -649.6% |
| 2018 | 0.31x | $10.56 Million | $34.14 Million | ▲ +103.9% |
| 2017 | -7.86x | $-23.72 Million | $3.02 Million | ▼ -94.1% |
| 2016 | -4.05x | $-13.16 Million | $3.25 Million | ▼ -426.0% |
| 2016 | -0.77x | $-5.08 Million | $6.60 Million | ▲ +72.4% |
| 2015 | -2.79x | $-20.86 Million | $7.48 Million | ▼ -2125.8% |
| 2015 | -0.13x | $-6.37 Million | $50.83 Million | ▲ +87.5% |
| 2014 | -1.00x | $-11.25 Million | $11.27 Million | ▼ -800.6% |
| 2014 | -0.11x | $-4.86 Million | $43.81 Million | ▼ -122.4% |
| 2013 | -0.05x | $-1.83 Million | $36.81 Million | — |